Q2 2026 Holdings
Filed 2026-08-13 | 15 holdings | $586.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $70.2M | 754,550 | 12.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $68.4M | 1,932,904 | 11.7% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $64.8M | 1,155,809 | 11.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $63.3M | 798,709 | 10.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $59.7M | 559,824 | 10.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $57.8M | 92,640 | 9.8% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $34.4M | 1,191,522 | 5.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $34.0M | 113,085 | 5.8% |
| Natera Inc(NTRA) | COM | 632307104 | $32.3M | 118,975 | 5.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $23.9M | 446,059 | 4.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $23.2M | 858,753 | 4.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $21.4M | 498,832 | 3.6% |
| Generate Biomedicines Inc(GENB) | COM SHS | 370920100 | $13.9M | 824,679 | 2.4% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $10.5M | 464,920 | 1.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $8.7M | 468,666 | 1.5% |